Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 29.47B | 30.85B | 28.03B | 29.22B | 28.16B | 25.94B |
Gross Profit | 7.73B | 8.14B | 6.95B | 7.92B | 8.07B | 7.21B |
EBITDA | 3.29B | 3.62B | 2.62B | 3.75B | 4.15B | 2.84B |
Net Income | 1.51B | 1.69B | 1.08B | 1.92B | 2.16B | 1.13B |
Balance Sheet | ||||||
Total Assets | 33.50B | 34.22B | 32.74B | 31.35B | 31.40B | 29.43B |
Cash, Cash Equivalents and Short-Term Investments | 4.87B | 5.85B | 5.16B | 5.74B | 5.35B | 5.02B |
Total Debt | 0.00 | 180.61M | 276.86M | 360.55M | 671.24M | 1.03B |
Total Liabilities | 8.71B | 9.06B | 8.79B | 8.00B | 8.56B | 7.95B |
Stockholders Equity | 24.79B | 25.16B | 23.95B | 23.36B | 22.40B | 21.09B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.45B | 382.15M | -248.79M | 1.81B | 1.70B |
Operating Cash Flow | 0.00 | 3.34B | 2.48B | 1.30B | 2.60B | 2.89B |
Investing Cash Flow | 0.00 | -2.14B | -2.10B | 1.02B | -766.54M | -1.19B |
Financing Cash Flow | 0.00 | -504.08M | -1.04B | -1.97B | -1.57B | -1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥21.06B | 8.59 | 3.09% | 8.26% | -23.43% | ||
80 Outperform | ¥25.00B | 8.17 | 4.54% | -0.35% | -14.20% | ||
77 Outperform | ¥10.62B | 11.63 | 2.51% | 7.00% | -28.12% | ||
76 Outperform | ¥17.25B | 10.75 | 2.75% | 9.52% | 17.71% | ||
72 Outperform | ¥19.61B | 12.53 | 4.18% | 3.78% | -2.21% | ||
63 Neutral | ¥2.79B | 14.08 | 6.31% | 2.82% | -140.06% | ||
61 Neutral | $17.23B | 11.50 | -5.97% | 3.09% | 1.49% | -16.00% |